Author: slightbourne@noblecapitalmarkets.com

Homebuyer Momentum Builds as Pending Home Sales Record Biggest Monthly Jump Since Early 2023

Posted on by slightbourne@noblecapitalmarkets.com

The U.S. housing market showed renewed signs of life in November as pending home sales posted their strongest monthly increase in nearly two years. New data from the National Association of Realtors reveals that contract signings rose 3.3% compared with October, far exceeding expectations and signaling that buyer activity may be stabilizing after a prolonged slowdown.

Pending home sales are considered a leading indicator for the housing market because homes typically go under contract one to two months before a sale is finalized. The November increase pushed the Pending Home Sales Index up to 79.2, a notable improvement even though the reading remains below the long-term benchmark of 100, which reflects average activity levels in 2001. Compared with November of last year, pending sales increased 2.6%, suggesting demand is gradually recovering.

One of the most important drivers behind the uptick in housing activity has been improving affordability. Mortgage rates have eased from their recent highs, providing relief to buyers who had been priced out of the market. The average rate on a 30-year fixed mortgage has hovered near 6.2% in recent months, down from approximately 7% earlier in 2025 and well below levels seen during the summer. Even modest declines in interest rates can significantly reduce monthly mortgage payments, encouraging more buyers to re-enter the market.

Slower home price growth has also contributed to rising buyer confidence. After years of rapid appreciation, price gains have moderated across much of the country, helping incomes catch up with housing costs. At the same time, wage growth has remained relatively strong, further supporting affordability and boosting purchasing power.

Regionally, pending home sales rose across all parts of the United States in November. The West recorded the largest month-over-month increase at 9.2%, reflecting strong pent-up demand in markets that were previously among the most constrained by affordability challenges. Gains in the Midwest, South, and Northeast suggest the recovery is becoming more evenly distributed rather than concentrated in isolated markets.

Inventory levels, while still tight by historical standards, have improved compared with last year. More homes available for sale have given buyers greater flexibility and reduced competitive pressures that previously discouraged many from making offers. This gradual improvement in supply has helped support the rise in contract activity without reigniting runaway price growth.

Despite the positive momentum, the housing market remains in a fragile recovery phase. Overall home sales in 2025 are still expected to rank near three-decade lows, underscoring how deeply elevated interest rates disrupted activity over the past several years. Many homeowners remain reluctant to sell because doing so would mean giving up ultra-low mortgage rates secured before 2022.

Looking ahead, housing market forecasts suggest a slow and uneven normalization rather than a sharp rebound. Continued declines in mortgage rates, steady wage growth, and incremental improvements in inventory will be critical to sustaining buyer demand. November’s surge in pending home sales does not mark a full recovery, but it does indicate that homebuyer momentum is building and that the long housing slowdown may be starting to ease.

This combination of improving affordability, stabilizing prices, and renewed buyer interest positions the housing market for a potentially stronger 2026 if current trends continue.

SoftBank to Pay $4 Billion for Data Center Firm DigitalBridge

Posted on by slightbourne@noblecapitalmarkets.com

SoftBank Group Corp. has agreed to acquire DigitalBridge Group Inc. in a cash deal valuing the digital infrastructure investor at approximately $4 billion, including debt. The transaction underscores SoftBank founder Masayoshi Son’s renewed push to dominate the backbone of the artificial intelligence economy: data centers, computing power, and the infrastructure required to scale AI globally.

Under the terms of the agreement, SoftBank will pay $16 per share for New York–listed DigitalBridge, representing a roughly 15% premium to the firm’s closing price on December 26. Shares of DigitalBridge jumped nearly 10% following the announcement, trading just below the offer price. The deal is expected to close in the second half of 2026, subject to regulatory approvals.

DigitalBridge is one of the largest global investors dedicated exclusively to digital infrastructure, managing roughly $108 billion in assets as of September. Its portfolio includes a roster of major data center and connectivity platforms such as Vantage Data Centers, Switch Inc., AtlasEdge, DataBank, Yondr Group, and AIMS. By acquiring DigitalBridge, SoftBank gains not only physical infrastructure exposure but also deep relationships with institutional investors actively deploying capital into data center development worldwide.

The acquisition comes amid an unprecedented surge in demand for data centers, driven by the rapid adoption of generative AI and cloud computing. Major players across finance and technology have poured capital into the sector. BlackRock’s $40 billion purchase of Aligned Data Centers and Oracle’s multiyear agreement to provide OpenAI with up to 4.5 gigawatts of computing power highlight the scale of investment reshaping the industry.

For SoftBank, the deal fits squarely into Son’s long-term vision of building an AI-centric ecosystem. Earlier this year, SoftBank announced the $500 billion “Stargate” initiative alongside OpenAI, Oracle, and Abu Dhabi-backed MGX, aiming to develop large-scale data centers across the United States. While the project’s rollout has been slower than initially promised due to financing challenges and site selection disputes, the DigitalBridge acquisition strengthens SoftBank’s strategic positioning in the infrastructure layer of AI.

The deal may also pave the way for further consolidation. SoftBank has reportedly held discussions about acquiring Switch Inc., one of DigitalBridge’s portfolio companies, at a valuation approaching $50 billion including debt. If pursued, such a move would further cement SoftBank’s influence over critical AI infrastructure assets.

Despite its reputation for high-profile technology bets—such as Alibaba, Arm Holdings, and the ill-fated WeWork investment—SoftBank has prior experience in asset management. Its 2017 acquisition of Fortress Investment Group, later sold in 2024, demonstrated Son’s willingness to operate across both technology and investment platforms.

Funding the AI push has required difficult trade-offs. Son recently disclosed that SoftBank sold a $5.8 billion stake in Nvidia to reallocate capital toward broader AI investments. The DigitalBridge acquisition signals that SoftBank is betting heavily that control of digital infrastructure—not just software or chips—will define the next phase of the AI revolution.

Nvidia’s $20 Billion Groq Deal Signals a New Phase in the AI Chip Arms Race

Posted on by slightbourne@noblecapitalmarkets.com

Nvidia is making its boldest strategic move yet in the artificial intelligence boom, agreeing to acquire key assets from AI chip startup Groq for roughly $20 billion in cash. The transaction, Nvidia’s largest deal on record, underscores how fiercely competitive the race to dominate AI infrastructure has become—and how much capital market leaders are willing to deploy to stay ahead.

Founded in 2016 by former Google engineers, including TPU co-creator Jonathan Ross, Groq has carved out a reputation for designing ultra-low-latency AI accelerator chips optimized for inference workloads. These are the chips that power real-time AI responses, an area of exploding demand as large language models move from experimentation into production across enterprises. While Groq was most recently valued at $6.9 billion in a September funding round, Nvidia’s willingness to pay nearly three times that figure for its assets highlights the strategic value of the technology rather than the startup’s current financials.

Structurally, the deal is notable. Nvidia is not acquiring Groq outright but instead purchasing its assets and entering into a non-exclusive licensing agreement for Groq’s inference technology. Groq will technically remain an independent company, with its cloud business continuing separately, while Ross and other senior leaders join Nvidia. This mirrors a growing trend among Big Tech firms: acquiring talent and intellectual property without the regulatory complexity of a full corporate takeover.

For Nvidia, the rationale is clear. CEO Jensen Huang has said the assets will be integrated into Nvidia’s AI factory architecture, expanding its platform to serve a broader range of inference and real-time workloads. As AI adoption matures, inference—not training—may become the dominant cost driver, and Groq’s low-latency processors directly address that bottleneck. The move also neutralizes a potential competitor founded by engineers who helped build one of Nvidia’s main alternatives: Google’s TPU.

From an investment perspective, the deal reinforces Nvidia’s commanding position in the AI ecosystem. The company ended October with more than $60 billion in cash and short-term investments, giving it unmatched flexibility to shape the market through acquisitions, licensing deals, and strategic investments. In recent months alone, Nvidia has struck similar agreements with Enfabrica, expanded its stake in CoreWeave, announced intentions to invest heavily in OpenAI, and even partnered with Intel. The Groq transaction fits neatly into this pattern of ecosystem consolidation.

Broader market sentiment also plays a role. Investors have rewarded Nvidia’s aggressive strategy, viewing it as a signal that AI spending is far from peaking. Rather than slowing, capital is concentrating around proven winners with scale, distribution, and cash. Smaller chip startups may still innovate, but exits increasingly appear to be strategic partnerships or asset sales rather than standalone IPOs—evidenced by Cerebras Systems shelving its public offering plans.

Ultimately, Nvidia’s Groq deal is less about one startup and more about the trajectory of the AI economy. It reflects a market where speed, efficiency, and control over the full AI stack are paramount. For investors, the message is clear: AI is entering a consolidation phase, and Nvidia intends not just to participate, but to dictate its direction.

Gold and Silver Shatter Records as Investors Flock to Hard Assets Amid Global Uncertainty

Posted on by slightbourne@noblecapitalmarkets.com

Precious metals are closing out the year with extraordinary momentum, underscoring a broader shift in global investment sentiment toward safety, scarcity, and real assets. Gold, silver, and platinum all surged to fresh all-time highs this week, extending one of the strongest rallies in modern market history and signaling growing unease beneath the surface of global financial markets.

Spot gold climbed above $4,530 an ounce, capping a year in which the metal has gained roughly 70%. Silver has been even more explosive, soaring more than 150% year-to-date and briefly crossing the $75 mark. Platinum, often overshadowed by its peers, has joined the rally with force, jumping more than 40% in December alone as supply deficits tighten and industrial demand rebounds.

At its core, the rally reflects a powerful shift in investor psychology. Heightened geopolitical tensions—from US actions in Venezuela to military operations in Africa—have revived gold’s traditional role as a safe-haven asset. At the same time, a weakening US dollar has amplified gains, making dollar-priced commodities more attractive to global investors. The Bloomberg Dollar Spot Index’s sharp weekly decline has provided fresh fuel for metals already in motion.

Monetary policy has played an equally important role. Three interest rate cuts by the US Federal Reserve this year have reduced the opportunity cost of holding non-yielding assets like gold and silver. With markets increasingly pricing in further easing in 2026, investors are positioning ahead of a prolonged low-rate environment. The result has been strong inflows into exchange-traded funds, particularly gold-backed vehicles, signaling institutional conviction rather than short-term speculation.

Beyond macro policy, deeper structural concerns are driving what many analysts describe as the “debasement trade.” Rising government debt levels, persistent fiscal deficits, and political pressure on central bank independence have eroded confidence in fiat currencies and sovereign bonds. In response, investors are reallocating toward tangible assets perceived as stores of value in an era of monetary experimentation.

Silver’s rally highlights another critical theme: supply constraints meeting financial leverage. Following a historic short squeeze earlier in the year, physical silver availability remains tight across key global hubs. While speculative positions continue to grow on paper, the limited supply of deliverable metal has intensified price pressures. Potential US trade restrictions on critical mineral imports have only added to the uncertainty, reinforcing silver’s dual appeal as both a monetary and industrial asset.

Platinum’s surge reflects similar dynamics. Persistent supply disruptions in South Africa, combined with strong demand from automotive and jewelry sectors, have pushed the market into its third consecutive annual deficit. As investors broaden their exposure beyond gold, platinum is increasingly viewed as an undervalued hedge with asymmetric upside.

Taken together, the record-breaking rally in precious metals is not an isolated phenomenon—it is a mirror of today’s investment landscape. While equity markets remain resilient, the surge in hard assets suggests investors are quietly hedging against volatility, policy risk, and currency erosion. As the year draws to a close, gold and silver’s ascent sends a clear message: confidence may be high on the surface, but caution is deeply embedded in global portfolios.

MariMed Inc (MRMD) – Rescheduling A Positive

Posted on by slightbourne@noblecapitalmarkets.com


Wednesday, December 24, 2025

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Rescheduling. In what many are calling the single greatest cannabis reform in U.S. history with far-reaching benefits for years to come, President Trump signed an Executive Order to speed up the rescheduling of marijuana from Schedule I to the less severe Schedule III by directing the Attorney General to “complete the rulemaking process” around rescheduling marijuana to Schedule III “in the most expeditious manner in accordance with Federal law.”

Benefits. From a broad perspective, reclassification means the Federal government officially acknowledges that cannabis has widely accepted medical uses and low abuse potential. Rescheduling will accelerate accredited medical research into medications derived from cannabis.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Great Lakes Dredge & Dock (GLDD) – Another Pause for Offshore Wind

Posted on by slightbourne@noblecapitalmarkets.com


Wednesday, December 24, 2025

Great Lakes Dredge & Dock Corporation is the largest provider of dredging services in the United States. In addition, Great Lakes is fully engaged in expanding its core business into the rapidly developing offshore wind energy industry. The Company has a long history of performing significant international projects. The Company employs experienced civil, ocean and mechanical engineering staff in its estimating, production and project management functions. In its over 131-year history, the Company has never failed to complete a marine project. Great Lakes owns and operates the largest and most diverse fleet in the U.S. dredging industry, comprised of approximately 200 specialized vessels. Great Lakes has a disciplined training program for engineers that ensures experienced-based performance as they advance through Company operations. The Company’s Incident-and Injury-Free® (IIF®) safety management program is integrated into all aspects of the Company’s culture. The Company’s commitment to the IIF® culture promotes a work environment where employee safety is paramount.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Another Pause. The Trump Administration is pausing leases for five offshore wind projects, including the Sunrise Wind and Empire Wind 1 projects, both of which Great Lakes’ soon to be delivered Acadia vessel is contracted to provide subsea rock services. Described as due to national security risks identified by the Pentagon, the pause is currently not expected to exceed 90 days. If accurate, the pause should not have a significant impact on Great Lakes, in our opinion.

Details. The administration said the pause will give the Interior Department, which oversees offshore wind, time to work with the Department of War and other agencies to assess the possible ways to mitigate any security risks posed by the projects. In past research, the U.S. government has found that the movement of turbine blades and the highly reflective towers can create radar interference called “clutter.” The clutter caused by offshore wind projects obscures legitimate moving targets and generates false targets in the vicinity of wind projects. However, these risks were already considered in the permitting process.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Comstock (LODE) – Rating Lowered to Market Perform from Outperform

Posted on by slightbourne@noblecapitalmarkets.com


Wednesday, December 24, 2025

Comstock (NYSE: LODE) innovates technologies that contribute to global decarbonization and circularity by efficiently converting under-utilized natural resources into renewable fuels and electrification products that contribute to balancing global uses and emissions of carbon. The Company intends to achieve exponential growth and extraordinary financial, natural, and social gains by building, owning, and operating a fleet of advanced carbon neutral extraction and refining facilities, by selling an array of complimentary process solutions and related services, and by licensing selected technologies to qualified strategic partners. To learn more, please visit www.comstock.inc.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Rating Lowered to Market Perform. While we had upgraded Comstock Inc. to Outperform on November 4, we have concluded our rating upgrade may have been too early, despite the share price appreciating ~33% from the date of our upgrade. It appears the company’s near-term capital needs remain significant, and we will reassess the value of the company’s businesses, once Comstock’s commercial scale recycling facility is operational and plans for the company’s mining assets are more fully realized. Moreover, we have been frustrated by the company’s promises to monetize non-core assets, including properties in Silver Springs, Nevada, without following through on its commitment. At this stage, we consider Comstock’s investment in Bioleum Corporation as a call option on its growth and success, which is subject to significant risk factors.

At the market offering. Comstock Inc. recently executed an At-the-Market Offering Agreement with Titan Partners Group LLC to offer and sell shares of common stock from time to time totaling up to $100.0 million. Titan Partners will be compensated at a commission rate equal to 3.0% of the gross sales price per share. Net proceeds will be used for general corporate purposes, including capital expenditures associated with commercializing subsequent industry scale and storage facilities for Comstock Metals, in addition to acquisitions, and technical, operational and human resource development expenses for supporting growth. Beyond acting as a headwind for capital appreciation, the ATM equity issuance could promote shareholder dilution.


Get the Full Report


Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Stock Market Today: S&P 500 Sets New 2025 Record as Wall Street Extends Winning Streak

Posted on by slightbourne@noblecapitalmarkets.com

U.S. stocks closed higher on Tuesday, pushing the S&P 500 to a fresh all-time high and extending Wall Street’s winning streak to four consecutive sessions, as investors looked past stronger-than-expected economic data and adjusted expectations around interest rate cuts.

The S&P 500 rose 0.46% to a record close of 6,909.79, marking its latest milestone in 2025. The tech-heavy Nasdaq Composite added 0.57%, while the Dow Jones Industrial Average gained a more modest 0.16%. The steady advance comes as equities rebound from recent volatility, with markets finding renewed momentum heading into the final trading days before the Christmas holiday.

Tuesday’s rally unfolded despite data showing the U.S. economy grew at a surprisingly robust pace over the summer. According to the first read on third-quarter gross domestic product, the economy expanded at a 4.3% annualized rate—well above the 3.3% economists had expected. The report, delayed earlier by government shutdown disruptions, also highlighted resilient consumer spending, reinforcing the view that economic activity remains strong even as borrowing costs stay elevated.

That strength prompted traders to dial back expectations for near-term interest rate cuts. Markets are now pricing in more than an 85% probability that the Federal Reserve will leave rates unchanged at its January meeting, up from roughly 75% just a week ago. While investors still anticipate two rate cuts by the end of next year, the timing appears less certain as economic data continues to show resilience.

Adding nuance to the outlook, December consumer confidence data from the Conference Board showed sentiment falling for a fifth straight month. The decline underscores a disconnect between hard economic data and consumer perceptions, suggesting households remain uneasy about inflation, interest rates, and the broader cost of living despite strong growth figures.

Beyond equities, commodities were a major highlight. Gold and silver prices continued their powerful rally, putting both precious metals on track for their strongest annual performance in more than 40 years. Copper also surged to a new record above $12,000 per ton, reflecting ongoing demand tied to infrastructure spending, electrification, and global supply constraints.

Corporate news added to the bullish tone. Shares of Novo Nordisk jumped after the Danish pharmaceutical giant received official U.S. approval to market its Wegovy weight-loss drug, reinforcing investor enthusiasm around the booming obesity treatment market. In the technology sector, megacap names led gains, with semiconductor stocks climbing and artificial intelligence heavyweight Nvidia helping lift the broader Nasdaq. Alphabet shares also advanced, contributing to the tech sector’s leadership.

Looking ahead, trading volumes are expected to thin as markets head into the holiday break. U.S. stock markets will close early on Wednesday and remain shut on Thursday for Christmas. Still, with the S&P 500 at record highs and investor optimism returning, attention is turning to whether a traditional “Santa Claus rally” could carry stocks into the new year, even as questions around interest rates and economic momentum remain firmly in focus.

Sanofi to Acquire Dynavax in $2.2 Billion Deal, Strengthening Its Adult Vaccine Portfolio

Posted on by slightbourne@noblecapitalmarkets.com

Sanofi has agreed to acquire Dynavax Technologies Corporation in an all-cash transaction valued at approximately $2.2 billion, a move that significantly bolsters the French drugmaker’s position in the adult vaccines market. Under the terms of the deal, Dynavax shareholders will receive $15.50 per share in cash, representing a 39% premium to the company’s closing share price on December 23, 2025.

The acquisition brings Sanofi a marketed adult hepatitis B vaccine, HEPLISAV-B®, along with a differentiated shingles vaccine candidate currently in Phase 1/2 development. Together, the assets enhance Sanofi’s immunization portfolio at a time when adult vaccination is increasingly viewed as a major growth opportunity within global healthcare.

HEPLISAV-B is Dynavax’s flagship product and is already approved and marketed in the United States, the European Union, and the United Kingdom. The vaccine stands out due to its two-dose regimen administered over one month, compared with traditional hepatitis B vaccines that require three doses over six months. This shorter schedule enables faster and higher rates of seroprotection, addressing a key barrier to adult vaccination adherence.

Sanofi executives emphasized that the transaction aligns with the company’s long-term vaccines strategy. Thomas Triomphe, Executive Vice President of Vaccines at Sanofi, said the deal adds “differentiated vaccines that complement Sanofi’s expertise” while reinforcing the company’s commitment to vaccine protection across the lifespan. With Sanofi’s global commercial infrastructure, HEPLISAV-B could see expanded adoption beyond its current markets.

In addition to its hepatitis B franchise, Dynavax brings a shingles vaccine candidate, Z-1018, which is currently in early-stage clinical development. Shingles represents a sizable and growing market, with the World Health Organization estimating that one in three adults will develop the condition during their lifetime. While Sanofi already has experience in vaccines, the addition of an early-stage shingles program provides optionality and long-term pipeline upside.

From a public health perspective, the acquisition targets areas of substantial unmet need. In the United States alone, nearly 100 million adults born before 1991 remain unvaccinated against hepatitis B, leaving them vulnerable to chronic infection that can lead to cirrhosis and liver cancer. Adult immunization has historically lagged childhood vaccination rates, creating a meaningful opportunity for growth and impact.

Financially, Sanofi plans to fund the acquisition using existing cash resources. The transaction has been unanimously approved by Dynavax’s board of directors and will proceed via a tender offer for all outstanding shares. Completion is subject to customary closing conditions, including regulatory approvals, and is expected in the first quarter of 2026.

Dynavax CEO Ryan Spencer said joining Sanofi will provide the scale and expertise needed to maximize the impact of the company’s vaccines. He described the transaction as delivering compelling value to shareholders while advancing Dynavax’s mission to protect against infectious diseases.

Overall, the deal underscores continued consolidation in the biotech and pharmaceutical sectors, particularly around vaccines and infectious disease prevention. For Sanofi, the acquisition of Dynavax represents both a near-term revenue opportunity through HEPLISAV-B and a longer-term pipeline investment as it looks to strengthen its leadership in adult immunization.

Fulgent Genetics Expands Pathology Footprint With $55.5 Million Acquisition of Bako Diagnostics and StrataDx

Posted on by slightbourne@noblecapitalmarkets.com

Fulgent Genetics is accelerating its transformation into a comprehensive precision diagnostics platform with the announced acquisition of selected assets of Bako Diagnostics and the full acquisition of StrataDx in a combined transaction valued at approximately $55.5 million. The deal, which will be funded entirely with cash on hand, is expected to close in the first half of 2026, subject to customary regulatory approvals.

The acquisition marks a strategic expansion of Fulgent’s laboratory services business, adding anatomic pathology services, proprietary PCR-based molecular tests, and a significantly broader national client base. Together, Bako Diagnostics and StrataDx bring deep expertise in specialty pathology and dermatopathology, positioning Fulgent to meaningfully strengthen its diagnostic offerings across multiple clinical touchpoints.

Bako Diagnostics, headquartered in Alpharetta, Georgia, is a premier national provider of specialty laboratory testing with a comprehensive menu that includes anatomic pathology, molecular genetic testing, and peripheral neuropathy immunohistochemical analysis. StrataDx, based in Lexington, Massachusetts, is a leading dermatopathology laboratory serving providers nationwide with advanced diagnostics for skin diseases, including melanocytic lesions, lymphomas, and complex dermatoses. Both laboratories are CLIA-certified, CAP-accredited, and licensed in their respective states.

Strategically, the transaction aligns closely with Fulgent’s long-term vision of becoming a one-stop diagnostic partner across the healthcare continuum. One of the most compelling aspects of the deal is the opportunity to apply Fulgent’s existing investments in digital pathology and artificial intelligence to Bako’s and StrataDx’s operations. Fulgent has already developed proprietary tools such as Eziopath, an image management system designed to enhance workflow efficiency, turnaround time, and diagnostic quality. Integrating these technologies is expected to increase capacity while maintaining high clinical standards.

The acquisition also significantly expands Fulgent’s test menu. Bako’s proprietary PCR assays offer faster turnaround times and cost efficiencies, strengthening Fulgent’s competitive position in molecular diagnostics. Combined with StrataDx’s dermatopathology expertise, the expanded portfolio allows Fulgent to serve a wider range of clinicians and patients with more comprehensive diagnostic solutions.

Commercial synergies represent another major driver of the transaction. Bako’s nationwide sales organization will nearly double the size of Fulgent’s pathology-focused sales team, immediately extending its commercial reach. The expanded client base creates additional opportunities to cross-sell existing Fulgent services, deepen payer relationships, and increase access to covered lives through managed care contracts.

Geographically, the acquisition enhances Fulgent’s laboratory footprint with additional certified facilities in Georgia and Massachusetts, including New York State–approved labs. This broader presence improves logistical efficiency and positions the company for future growth in regulated markets.

Ming Hsieh, Chairman and CEO of Fulgent Genetics, emphasized the strategic fit of the deal, highlighting the company’s ability to layer new pathology services onto a rapidly growing laboratory platform while leveraging AI to drive efficiency and quality. Bako and StrataDx leadership echoed that sentiment, pointing to the benefits of combining specialized diagnostic expertise with Fulgent’s technology-driven infrastructure.

As healthcare increasingly shifts toward precision medicine, Fulgent’s acquisition of Bako Diagnostics and StrataDx represents a calculated step toward scale, integration, and long-term growth in advanced diagnostics.

The GEO Group (GEO) – Expansion of Services

Posted on by slightbourne@noblecapitalmarkets.com


Tuesday, December 23, 2025

The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO’s diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care®, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO’s worldwide operations include the ownership and/or delivery of support services for 103 facilities totaling approximately 83,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 18,000 employees.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

New Award. GEO Group’s BI subsidiary has been awarded a contract by ICE for the provision of skip tracing services. Skip tracing services entail enhanced location research with identifiable information, commercial data verification, and physical observation to verify current address information and investigate alternative address information for individuals on the federal government’s non-detained docket. We view the announcement favorably and continue to believe there will be additional business to follow from ICE and GEO’s other government partners.

Details. The new contract has a term of two years, with an initial term of one year, effective  December 16, 2025, and an additional one-year period. The estimated revenue value of the two-year contract is up to approximately  $121 million. The format appears similar to the recent ISAP award won by BI, in our view.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

ACCO Brands (ACCO) – An Acquisition Expands the Offerings

Posted on by slightbourne@noblecapitalmarkets.com


Tuesday, December 23, 2025

ACCO Brands Corporation is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include AT-A-GLANCE®, Esselte®, Five Star®, GBC®, Kensington®, Leitz®, Mead®, PowerA®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Acquisition. ACCO is acquiring EPOS, which provides a comprehensive range of premium enterprise wired and wireless headsets, and other audio solutions. The transaction enhances and broadens ACCO’s Kensington computer accessories portfolio into the large global enterprise headset category, estimated at $1.7 billion in size. We believe the acquisition aligns with management’s strategy to invest in markets with better growth profiles. The addition of EPOS will allow ACCO to deliver a more complete line of workspace technology accessory solutions to enterprise customers.

Details. The transaction is valued at $11.7 million, including up to $3.5 million in deferred payments, and will be funded by existing cash resources. The deal is expected to close in January 2026. EPOS generates approximately $80 million in annual revenue. ACCO expects to achieve cost synergies in the range of $10-$15 million over the next two years. ACCO expects to take approximately $7 million of restructuring charges. Management expects 2026 profit to be modestly positive.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Kuya Silver (KUYAF) – Umm Hadid: Early-Stage Discovery

Posted on by slightbourne@noblecapitalmarkets.com


Tuesday, December 23, 2025

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

High-grade silver-gold system confirmed. Kuya Silver reported strong initial exploration results from the Umm Hadid Project in Saudi Arabia, confirming high-grade silver-gold mineralization over a large area measuring approximately 6.0 km by 2.5 km. In our view, the scale of the mineralized footprint and grade tenor materially de-risks the project at an early stage. Umm Hadid is operated by Silver Mining LLC, a joint venture between Sumou Holding and Kuya Silver.

Maiden drilling validates surface results. The first drill program comprised 29 diamond drill holes totaling roughly 5,000 meters across three target areas defined by surface sampling. Drilling returned high-grade intercepts of up to 1,483.9 g/t silver equivalent over two meters, with several additional intersections grading several hundred grams per tonne. Surface sampling of 460 grab samples averaged 86.1 g/t silver equivalent, with peak values reaching 1,359.8 g/t. We believe a strong gold-silver correlation supports the presence of a large hydrothermal system.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.